尽管庆大霉素、卡那霉素、西梭霉素和福提霉素的某些衍生物其抗菌作用显著增强,但在毒性和疗效上,过去十年中没有一个新品种优于丁胺卡那霉素,估计近五年内也不会有更优良的新品种。氢基糖甙类抗生素将在若干年内继续在临床应用,并作为免疫功能不全和严重感染治疗的重要药物。 Although some of the derivatives of gentamicin, kanamycin, sisamycin and fotatomycin have significantly increased antibacterial activity, none of the new breeds over the last decade have been superior to amikacin in toxicity and efficacy It is estimated that there will be no better new varieties in the past five years. Hydrogen glycoside antibiotics will continue to be used clinically for a number of years and will serve as an important drug for the treatment of immunocompromised and severe infections.